Piracetam in alcoholic organic mental disorder: a placebo controlled study comparing two dosages. 1986

W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller

The following paper presents an investigation of the efficacy of piracetam in alcoholic organic mental disorder. A double-blind placebo-controlled study design was used to compare 2 dosages of the substance (2 X 3 g vs. 2 X 12 g). Cognitive function was assessed on days 0, 7, 14, 28, 42. Analysis of the results from 24 patients showed a clear-cut amelioration of cognitive functions in all 3 treatment groups. No difference could be demonstrated between the administration of placebo and the lower dose of piracetam. Patients on the higher dose showed an earlier improvement on one of the tests, but the final scores were similar in all three treatment groups.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
January 1985, The Journal of international medical research,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
January 1987, Progress in neuro-psychopharmacology & biological psychiatry,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
March 1998, Journal of neurology, neurosurgery, and psychiatry,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
September 1999, The Journal of clinical psychiatry,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
January 1981, Psychopharmacology bulletin,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
September 2008, Child psychiatry and human development,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
March 2010, British journal of clinical pharmacology,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
August 1976, Acta psychiatrica Scandinavica,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
January 1978, The Journal of rheumatology. Supplement,
W W Fleischhacker, and V Günther, and C Barnas, and F Lieder, and C Miller
January 2007, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Copied contents to your clipboard!